Scientists using cutting-edge AI to analyse medical data have been able to predict a person’s risk of developing conditions such as Alzheimer’s and heart disease up to 10 years before a diagnosis: August 2024 Image Researchers used machine learning to study blood samples from more than 45,000 people. AI tools were able to identify patterns of proteins present in the blood linked to increased risk of disease, allowing researchers to accurately predict a person’s probability of developing a condition before symptoms appear. Being able to detect early warning signs for a broad set of conditions may lead to opportunities for early intervention and prevention, experts say. Early stages The study team, which involved researchers from the University of Edinburgh and commercial collaborators Optima Partners and Biogen, analysed blood samples from the UK Biobank – a database of genetic and health information from 500,000 UK participants. They used AI and machine learning tools to identify protein patterns in the blood that were indicative of the development of common conditions including Alzheimer’s, heart disease and type 2 diabetes. The disease diagnosis information was taken from the medical records of the participants up to 10 years after the blood sample measurements. The team then tested whether the patterns could be used to diagnose conditions in the blood samples of a separate group of individuals, whose data had not been used to create the protein patterns. They found that the protein patterns improved prediction accuracy beyond traditional risk factors such as age, sex, lifestyle behaviours, cholesterol and other commonly measured clinical variables. Implementation of this form of analysis is not expected to be immediate, but experts say their research is a promising step forwards in risk prediction. The study is published in the journal Nature Aging and was funded by Wellcome. It’s encouraging to see how much potential there is from a single blood sample that allow us to predict a range of disease outcomes. Being able to detect early warning signs for a broad set of conditions may lead to opportunities for early intervention and prevention, marking a significant moment for the healthcare industry.Dr Danni GaddPhD student, Centre for Genomic & Experimental Medicine, University of EdinburghMore work is still needed to convert these findings for practical use in clinical settings. However, our discoveries set strong foundations for the inclusion of new risk prediction signatures to shed light on possible pathways and mechanisms that underlie diseases. Pattern recognition like this would not be possible without modern machine learning technology, and its capacity to analyse data at this scale, and this will in turn allow us to address some of the most pressing healthcare challenges of our time.Dr Chris FoleyManaging Director and Chief Scientist of Optima PartnersRelated linksRead the full paper in Nature Aging Image credit: Tom Werner via Getty Images Tags 2024 Publication date 10 Sep, 2024
